10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $87 | -99.9% | 4,700 | -11.0% | 0.01% | +40.0% |
| Q3 2022 | $79,000 | +507.7% | 5,280 | +1660.0% | 0.01% | +400.0% |
| Q2 2022 | $13,000 | -82.9% | 300 | -95.5% | 0.00% | -75.0% |
| Q1 2022 | $76,000 | -46.9% | 6,700 | +69.6% | 0.00% | -33.3% |
| Q4 2021 | $143,000 | +32.4% | 3,950 | -42.3% | 0.01% | +20.0% |
| Q3 2021 | $108,000 | -24.5% | 6,850 | +661.1% | 0.01% | -16.7% |
| Q2 2021 | $143,000 | +297.2% | 900 | +350.0% | 0.01% | +200.0% |
| Q1 2021 | $36,000 | -93.7% | 200 | -98.6% | 0.00% | -92.3% |
| Q4 2020 | $567,000 | +107.7% | 14,020 | +15.9% | 0.03% | +62.5% |
| Q3 2020 | $273,000 | +178.6% | 12,100 | +0.8% | 0.02% | +166.7% |
| Q2 2020 | $98,000 | +108.5% | 12,000 | +328.6% | 0.01% | +100.0% |
| Q1 2020 | $47,000 | +571.4% | 2,800 | +1300.0% | 0.00% | – |
| Q4 2019 | $7,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |